Study identifies risk factors for progression of smoldering multiple myeloma
This article has no abstract so we have provided the first paragraph of the full text.
Patients with smoldering multiple myeloma—an asymptomatic proliferative disorder of plasma cells—are at high risk of progression to active multiple myeloma. In a recent paper, Kyle et al. report that the risk of progression to symptomatic disease is associated with the proportion of plasma cells in the bone marrow, and the serum monoclonal protein level, at diagnosis.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.